MKS Inc. to Participate in Needham’s 28th Annual Growth Conference

MKS Inc. to Participate in Needham's 28th Annual Growth Conference GlobeNewswire January 05, 2026 ANDOVER, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that John T.C. Lee, President and Chief Executive Officer, will participate in a fireside chat at Needham's […]

Uni-Fuels Advances Global Operations with Next Phase of Expansion

Uni-Fuels Advances Global Operations with Next Phase of Expansion GlobeNewswire January 05, 2026 SINGAPORE, Jan. 05, 2026 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced the next phase of its global expansion strategy, focused on scaling its global operations

*MEDIA ALERT* Verizon and David Beckham Kick Off Third Wave of Verizon Ultimate Access, Dropping Free FIFA World Cup 2026(TM) Tickets Exclusively for Customers

*MEDIA ALERT* Verizon and David Beckham Kick Off Third Wave of Verizon Ultimate Access, Dropping Free FIFA World Cup 2026(TM) Tickets Exclusively for Customers GlobeNewswire January 05, 2026 NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — WHAT: Verizon is back with David Beckham to announce the third Verizon Ultimate Access ticket drop for FIFA World

Business First Bancshares, Inc. Completes Acquisition of Progressive Bank

Business First Bancshares, Inc. Completes Acquisition of Progressive Bank GlobeNewswire January 05, 2026 BATON ROUGE, La., Jan. 05, 2026 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST) (Business First), the holding company for b1BANK, announced today the successful completion of its previously announced acquisition of Progressive Bancorp, Inc. (Progressive) and its wholly-owned bank subsidiary,

Wyld Acquires Gron in Major Industry Transaction

Wyld Acquires Gron in Major Industry Transaction Two Of The Cannabis Industry's Most Acclaimed And Successful Edibles Brands Are Joining Forces, Combining Their Market Expertise, Distribution Networks And Product Innovation Pipelines To Create The Unquestioned Leader In Cannabis Edibles GlobeNewswire January 05, 2026 PORTLAND, Ore., Jan. 05, 2026 (GLOBE NEWSWIRE) — Wyld, the most recognized

Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning

Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning GlobeNewswire January 05, 2026 ENGLEWOOD, Colo., Jan. 05, 2026 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels and chemicals, and carbon management, today announced the addition of agricultural industry veteran Greg Hanselman as executive vice president, operations and engineering. Mr. Hanselman's

Wearable Devices Brings Neural Input to the Center of the Smart-Glasses Ecosystem at CES 2026

Wearable Devices Brings Neural Input to the Center of the Smart-Glasses Ecosystem at CES 2026 GlobeNewswire January 05, 2026 Visitors will experience neural-click speed testing, gesture creation and smart-screen control powered by the Mudra Link Yokneam Illit, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”),

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT(R) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT(R) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) GlobeNewswire January 05, 2026 – Initial module submission marks an important milestone in the pre-market approval process – – Flexible modular submission framework granted to Alpha Tau by the FDA allows for

YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap

YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap GlobeNewswire January 05, 2026 Taipei, Taiwan, Jan. 05, 2026 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced the successful completion of critical

Scroll to Top